Skip to content

Clinical trials

Observational Schizophrenia trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Observational Country / region: South Korea Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20061
20075
20093
20101
20113
20123
20131
20141
20161
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status9
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital9
AstraZeneca3
Seoul National Hospital3
Asan Medical Center2
Korea Otsuka Pharmaceutical Co., Ltd.2
Inje University1
Janssen Korea, Ltd., Korea1
Korea University Guro Hospital1
Samsung Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia23
Metabolic Syndrome4
Psychotic Disorders3
Bipolar Disorder2
Alcoholism1
Drug-Related Side Effects and Adverse Reactions1
Hallucinations1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.